TQ Course | Therapeutic Innovations The Game Changers (2/23/2021) by Optometric Education Consultants | Feb 23, 2021 | TQ Courses | 0 comments HiddenDate (Hidden) MM slash DD slash YYYY 1. Humira (adalimumab) subcutaneous injection is on label for which ocular diagnosis?* A - Noninfectious posterior uveitis B - Diabetic macular edema C - RPE65 biallelic mutation D - Exudative macular degeneration 2. What is the difference between generic latanoprost 0.005% and Xelpros (latanoprost ophthalmic emulsion 0.005%)?* A - Mechanism of action B - Preservative C - Active ingredient D - Dosage 3. The most common side effect of Rho kinase inhibitors is:* A - Corneal verticillata B - Conjunctival hyperemia C - Intraocular inflammation D - Iris color change 4. What is the trade name of the most recently approved bimatoprost sustained-release implant?* A - Durysta B - Durezol C - Dexycu D - DARPin 5. Following three monthly loading dose injections of Beovu (brolucizumab), the on-label dosing for neovascular macular degeneration is:* A - Every two weeks B - Every four weeks C - Every twelve weeks D - Every sixteen weeks 6. Which of the following is NOT part of the general trend in the development of new therapies in retinal vascular disease?* A - Decreased amount of time between treatments B - Development of alternative routes of administration of medication C - Improvement of patient quality of life D - Reduction in the cost of treatment 7. Intravitreal brimonidine is currently being investigated for the treatment of:* A - Neovascular macular degeneration B - Geographic atrophy C - Macular edema following retinal vein occlusion D - Polypoidal choroidal vasculopathy 8. Advantages of smaller molecule anti-VEGF agents include:* A - Higher systemic exposure B - Slower clearance C - Improved tissue penetration D - Greater required medication volume 9. Oxervate (cenegermin-bkbj ophthalmic solution 0.002%) is on label for the treatment of:* A - Thyroid eye disease B - Neurotrophic keratitis C - Dry eye disease D - Herpes simplex epithelial keratitis 10. Rocklatan (netarsudil 0.02%/latanoprost 0.005%) dosage is correctly described as:* A - Every other day B - Once daily in the evening C - Twice daily D - Three times daily Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongo, Democratic Republic of theCongo, Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatini (Swaziland)EthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth GeorgiaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaVietnamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code Therapeutic Innovations The Game Changers | TQ Credit*After 4/23/2021, pricing will increase to $30. Price: (Past 60 Days) Therapeutic Innovations The Game Changers | TQ Credit Price: This course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30.Retake Discount Price: (Past 60 Days) Retake Discount Price: Payment Method*Please note, the charge on your card statement will appear from WeyesGeyes, not Optometric Education Consultants. WeyesGeyes is the LLC that Optometric Education Consultants does business under.PayPal Checkout American ExpressDiscoverMasterCardVisaSupported Credit Cards: American Express, Discover, MasterCard, Visa Card Number Card Number Expiration Date Expiration Date Security Code Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
